Thermo Fisher Scientific Inc ($TMO) Stock Forecast: Down 1.4% Today

What is Thermo Fisher Scientific Inc?

Thermo Fisher Scientific (NYSE: TMO) is a leading biotechnology company specializing in various scientific tools and services, catering to research, healthcare, and environmental markets. The company is known for its innovative solutions and consistent growth in the industry.

Why is Thermo Fisher Scientific Inc going down?

TMO stock is down 1.4% on Jul 1, 2024 14:55

• The bearish movement in TMO's stock today may be due to changes in investor focus within the biotech sector.
• The decline in vaccine sales post-pandemic and the current emphasis on long-term health solutions could be prompting investors to adjust their portfolios away from companies like TMO.
• Significant fund investors taking a bullish stance on TMO, as evidenced by options market data, could imply a short-term market correction rather than a sustained trend, which may be influencing today's bearish movement.
• It is crucial for traders to monitor evolving market dynamics, changing trends, and investor sentiments to make informed decisions within the biotech sector.

TMO Price Chart

TMO News

You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.

Biotech stocks to buy now reflect a more dynamic shift in investor focus of late. Over the past few years, the biotech space attracted plenty of investor interest, driven by the Covid-19 pandemic. Global vaccine sales for the crippling virus were upwards of $142 billion from 2020 to 2023. The vaccine rollout was hugely successful across the globe, especially in countries like the U.S., U.K. and Germany. Now, a couple of years after the lifting of lockdown restrictions worldwide, the buzz around vaccines has quieted. Vaccine sales are expected to drop substantially, with just $24.2 billion in sales expected over the next four years. However, with the pandemic firmly in the rear-view mirror, the focus has shifted towards biotech firms developing long-term solutions for chronic conditions. That said, here are three compelling biotech stocks that fit the bill and have the potential to brighten up your investment portfolios. These companies spearhead the development of enduring therapies for recurrent long-term health problems.

https://investorplace.com/2024/06/youve-been-warned-3-biotech-stocks-to-buy-now-or-regret-forever/

You’ve Been Warned! 3 Nanotech Stocks to Buy Now or Regret Forever

Nanotech stocks are among the hottest plays in the market right now, thanks to analysts predicting astronomical growth for the market. For example, Fortune Business Insights forecasted the market would grow to $91.18 billion in 2024 and reach $332.73 billion by 2032. The CHIPS Act and other legislative moves by the U.S. are further bolstering the appeal of investing in nanotech stocks, committing $52.7 billion in semiconductors, including $39 billion in manufacturing incentives and $13.2 billion in R&D and workforce development. The National Nanotechnology Initiative (NNI) is perhaps the biggest undertaking regarding the tech concept on U.S. shores, with 30 federal agencies participating in the initiative, underscoring the importance of nanotechnology, which bodes well for stocks in the space as well. To achieve national objectives, the highest-ever NNI budget request is $2.16 billion in 2024 for basic and application-driven R&D. Because of the trade war with China, the number is likely to go up; China has the most nanotech startup companies in the world. Considering the strategic importance of nanotech stocks, the market size on offer and the U.S. government taking this area very seriously, it’s no surprise investors are encircling this area. But the methodology to select nanotech stocks needs to be simple: Do not go for stocks rated laggards by analysts, and don’t invest in stocks without any upside left. Having a streak of earnings beats also helps.

https://investorplace.com/2024/06/youve-been-warned-3-nanotech-stocks-to-buy-now-or-regret-forever/

What the Options Market Tells Us About Thermo Fisher Scientific - Thermo Fisher Scientific ( NYSE:TMO )

Investors with significant funds have taken a bullish position in Thermo Fisher Scientific TMO, a development that retail traders should be aware of. This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga.

https://www.benzinga.com/insights/options/24/06/39460718/what-the-options-market-tells-us-about-thermo-fisher-scientific

Trending Today

ON Semiconductor Corporation ($ON) Stock Forecast: Up 0.4% Today

Floki ($FLOKI) Crypto Forecast: Down 7.5% Today

Reddit Inc ($RDDT) Stock Forecast: Up 5.6% Today

Rocket Companies Inc ($RKT) Stock Forecast: Up 5.1% Today

Polygon ($MATIC) Crypto Forecast: Down 5.1% Today

Nikola corporation ($NKLA) Stock Forecast: Down 6.3% Today

Worldcoin ($WLD) Crypto Forecast: Up 9.0% Today

Jupiter ($JUP) Crypto Forecast: Down 5.5% Today

Sirius XM Holdings Inc. ($SIRI) Stock Forecast: Up 15.3% Today

Tesla Inc. ($TSLA) Stock Forecast: Up 6.5% Today

Thermo Fisher Scientific Inc Price History

23.03.2024 - TMO Stock was up 5.0%

• Thermo Fisher Scientific is experiencing a surge in options activity, with deep-pocketed investors adopting a bullish approach towards the company, indicating confidence in its future prospects.
• The positive outlook for the Cell Cryopreservation Market, in which Thermo Fisher Scientific is a key player, could be contributing to the bullish movement as investors anticipate increased demand for the company's products and services.
• The overall market is eagerly awaiting key events such as the US core PCE print and corporate earnings reports, with Thermo Fisher Scientific standing out as a potential attractive valuation option, further attracting investors to the stock.
• The combination of favorable market conditions, positive industry trends, and investor sentiment towards Thermo Fisher Scientific could be driving the stock's strong bullish movement today.

01.01.2024 - TMO Stock was down 5.1%

• The bearish movement in TMO's stock today could be attributed to the warning about lower-than-expected demand for 2024. This news may have raised concerns among investors about the company's future growth prospects. Additionally, the overall market sentiment towards biotech companies and their product spending could have contributed to the downward movement.

31.09.2023 - TMO Stock was up 5.4%

• Unusual options activity suggests a bullish stance on TMO, indicating positive sentiment among investors.
• The acquisition of new positions by Peterson Financial Group Inc. and Apollon Wealth Management LLC also indicates confidence in TMO's growth potential.
• The reduction in stock holdings by Cognios Beta Neutral Large Cap Fund LP may be a minor factor, but overall sentiment remains bullish.
• The upgrade in rating to "Buy" by StockNews.com further supports the positive outlook for TMO.
• Overall, the bullish movement in TMO's stock today can be attributed to the positive sentiment among investors, as indicated by unusual options activity and the acquisition of new positions by prominent financial firms.

25.09.2023 - TMO Stock was down 6.0%

• Thermo Fisher Scientific Inc. (TMO) experienced a strong bearish movement today.
• The company reported lower revenues in its third quarter, with a 1% decrease compared to the previous year.
• Thermo Fisher also lowered its full-year financial outlook, citing weak biotech demand and a challenging macro environment.
• This news of lower revenues and a lowered outlook likely contributed to the bearish movement in TMO's stock price.

02.09.2023 - TMO Stock was down 1.7%

• Thermo Fisher Scientific (TMO) experienced a strong bearish movement today.
• The stock rating for TMO was lowered by StockNews.com.
• Despite the overall market dip, TMO managed to gain slightly.
• The bearish movement could be attributed to Bernstein's bearish outlook on Illumina, a competitor in the medtech industry.

25.06.2023 - TMO Stock was up 1.5%

• Thermo Fisher Scientific (TMO) had a strong bullish movement today, and here's why:
• Thermo Fisher Scientific has consistently outperformed the market over the past 15 years, with an average annual return of 16.42%. This long-term track record of success likely contributed to the bullish movement.
• Despite a slight dip of -0.3% in the previous trading session, the overall market gains and positive outlook for Thermo Fisher in the second quarter earnings report could have boosted investor confidence and led to the bullish movement.
• The favorable business mix and new launches by Thermo Fisher in the second quarter are expected to have driven growth, further supporting the bullish movement.
• In summary, Thermo Fisher Scientific's strong bullish movement today can be attributed to its consistent outperformance, positive market sentiment, and anticipated growth in the second quarter.

19.06.2023 - TMO Stock was up 2.4%

• Thermo Fisher Scientific (TMO) had a bullish market movement today.
• The positive market movement could be attributed to the company's strong performance in the second quarter, driven by a favorable business mix and new product launches.
• Additionally, the long-term outperformance of TMO in the market, as highlighted in an article from Benzinga, may have contributed to investor confidence and further buying interest in the stock.
• The launch of Thermo Fisher's Diomni Enterprise Software, as mentioned in an article from Zacks Commentary, could have also generated positive sentiment and potential growth prospects for the company.

10.06.2023 - TMO Stock was up 0.8%

• The bullish movement in TMO stock today could be attributed to the following factors:
• 1. Acquisition of CorEvitas: Thermo Fisher Scientific agreed to acquire biopharmaceutical data provider CorEvitas from Audax Group for $913 million in cash. This strategic acquisition could enhance Thermo Fisher's data intelligence capabilities and expand its presence in the biopharmaceutical industry.
• 2. Positive market sentiment: Despite concerns raised by Cleveland Research about demand in the toolmakers industry, Thermo Fisher Scientific's strong position in the life sciences sector and its continued growth potential may have instilled confidence among investors, leading to the bullish movement.
• 3. Strong performance: Thermo Fisher Scientific is known for its consistent performance and strong financials. The company's ability to navigate through tough comparables and its resilience during the pandemic may have contributed to the positive market sentiment and the bullish movement in its stock.

27.05.2023 - TMO Stock was down 2.9%

• Thermo Fisher Scientific Inc. (TMO) had a strong bearish movement today.
• The market movement might have been caused by the lack of any significant news related to TMO, as none of the provided articles mentioned any major developments or events.
• It is possible that investors may have taken profits after a recent uptrend in TMO's stock price.
• The overall market sentiment could also be a factor, as the broader market indices experienced a mixed day of trading.

24.04.2023 - TMO Stock was down 3.8%

• Thermo Fisher Scientific's stock had a bearish movement today, despite the company's recent announcement of CEO Marc N. Casper's presentation at the Bernstein 39th Annual Strategic Decisions Conference.
• The FDA approval of Thermo Fisher's blood test for preeclampsia, a pregnancy-related illness and death, could have been a positive catalyst for the stock, but it did not seem to have a significant impact on the market movement.
• The pharmaceutical filtration market is expected to be worth $21.96 billion by 2030, which could potentially benefit Thermo Fisher Scientific as a leading provider of scientific filtration solutions.
• The article mentioning Thermo Fisher Scientific as a standout large-cap stock for long-term upside did not seem to have a positive impact on the stock's movement today.